We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The EU has exercised its option to purchase 100 million additional doses of Pfizer/BioNTech’s two-dose COVID-19 vaccine, putting the trade bloc in line to receive 600 million shots in total this year as it clamors for additional supplies to boost its vaccination efforts. Read More
A bench trial in a 2019 lawsuit by Ferring Pharmaceuticals against generic drug giant Lupin Pharmaceuticals gets under way today, with Ferring alleging that the generic drugmaker sought to infringe on a patent for its prescription drug Clenpiq, a drinkable bowel cleanser. Read More
Novartis has agreed to help manufacture Roche’s blockbuster rheumatoid arthritis drug Actemra (tocilizumab) as a COVID-19 treatment — in another pact that offers the company’s manufacturing might to help produce a rival’s COVID-19 therapies or vaccines. Read More
The ranks of the top-earning contract research organizations (CROs) continued to shift this week as Thermo Fisher Scientific announced it will acquire PPD, one of the industry’s largest CROs, for $17.4 billion in cash plus the assumption of about $3.5 billion of net debt. Read More
Earlier this week, Sanofi announced that it will invest $476 million in a multi-vaccine manufacturing facility in Singapore to mass-produce vaccines for the Asian market. Read More
The company’s COVID vaccine could receive UK approval as soon as this month, based off strong UK phase 3 data, and Emergency Use Authorization in the U.S. could occur in May. Read More
Pfizer has accelerated COVID-19 vaccine production and is on track to distribute 300 million doses in the U.S. before the end of July, said the company’s CEO Albert Bourla. Read More
Sanofi has announced that it will invest $476 million in a multi-vaccine manufacturing facility in Singapore to mass produce vaccines for the Asian market. Read More
In a much-needed development, Johnson & Johnson began delivery of its one-shot COVID-19 vaccine within the EU yesterday as the trade bloc continues to clamor for enough doses to inoculate its 446 million residents. Read More